ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Cleveland, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Cleveland, OH, USA:

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. (BRIA-ABC)

Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...

Enrolling
Breast Cancer
Breast Neoplasm
Drug: Cyclophosphamide
Drug: Interferon infiltration of the inoculation site

Phase 3

BriaCell Therapeutics

Cleveland, Ohio, United States and 35 other locations

The purpose of this study is to find out the possible anti-cancer effect of pelareorep in combination with chemotherapy \[paclitaxel\] and a ...

Active, not recruiting
Breast Cancer Metastatic
Drug: Avelumab
Drug: Paclitaxel

Phase 2

Oncolytics Biotech

Cleveland, Ohio, United States and 17 other locations

participants with metastatic or locally advanced Hormone Receptor (HR) positive and Human Epidermal Growth Factor Receptor (HER)2-negative breast...

Active, not recruiting
Breast Cancer
Locally Advanced Breast Cancer
Drug: Elacestrant Dihydrochloride
Drug: Samuraciclib

Phase 1, Phase 2

Carrick Therapeutics

Cleveland, Ohio, United States and 22 other locations

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Cleveland, Ohio, United States and 226 other locations

This study will look to establish the recommended biologic dose of AE37 in combination with pembrolizumab that will enhance the tumor-specif ...

Active, not recruiting
Triple-negative Breast Cancer
Biological: Pembrolizumab
Biological: AE37 Peptide vaccine

Phase 2

NuGenerex Immuno-Oncology

Cleveland, Ohio, United States and 5 other locations

(Part 2). The primary purpose of Dose Expansion (Part 2) is to assess the antitumor activity of BB-1701 at RD in the selected population(s) of breast...

Enrolling
Breast Cancer
Drug: BB-1701

Phase 2

Eisai
Eisai

Cleveland, Ohio, United States and 30 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Enrolling
Advanced Breast Cancer
Drug: ARV-471
Drug: Fulvestrant

Phase 3

Pfizer
Pfizer

Cleveland, Ohio, United States and 446 other locations

with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...

Active, not recruiting
Breast Cancer
Drug: Eribulin
Drug: Vinorelbine

Phase 3

AstraZeneca
AstraZeneca

Cleveland, Ohio, United States and 166 other locations

with anti-HER2 antibodies in patients with HER2-negative invasive breast cancer who have abnormal HER2 signaling activity determine...

Enrolling
HER2-negative Breast Cancer
Drug: Doxorubicin
Drug: Cyclophosphamide

Phase 2

National Surgical Adjuvant Breast and Bowel Project Foundation (NSABP)

Cleveland, Ohio, United States and 42 other locations

evidence-proven optimal management of curable neurologic conditions. Breast cancer is the most common cancer in African-Am...

Enrolling
Breast Cancer
Prostate Cancer
Behavioral: NAVAH
Case Comprehensive Cancer Center (Case CCC)
Case Comprehensive Cancer Center (Case CCC)

Cleveland, Ohio, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems